Results 241 to 250 of about 5,219,598 (385)

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

open access: yesMolecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser   +14 more
wiley   +1 more source

Quantum Computing for Transport Network Optimization. [PDF]

open access: yesEntropy (Basel)
Ju J   +7 more
europepmc   +1 more source

Computers and Computing in Society [PDF]

open access: yesNTM Zeitschrift für Geschichte der Wissenschaften, Technik und Medizin, 2020
openaire   +2 more sources

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

open access: yesMolecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu   +18 more
wiley   +1 more source

Editorial: Novel computational fluid dynamics methods for diagnosis, monitoring, prediction, and personalized treatment for cardiovascular disease and cancer metastasis

open access: yesFrontiers in Bioengineering and Biotechnology
Zahra Keshavarz Motamed   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy